SKI Market

A+| A| A-|

Indian Indices

Sensex

78,516.49 -756.84
( -0.95%)

Global Indices

Nasdaq

49,166.17 -297.40
(-0.60%)

Dow Jones

7,084.21 -45.93
(-0.64%)

Hang Seng

59,542.04 192.87
(0.32%)

Nikkei 225

10,480.54 -17.55
(-0.17%)

Forex

USD-INR

92.99 0.41
(0.45%)

EUR-INR

109.45 0.58
(0.53%)

GBP-INR

125.69 0.62
(0.49%)

JPY-INR

0.59 0.00
(0.33%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Influx Healthtech Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

93847

INE0MYZ01012

36.3489357

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

INFLUX

46.16

616.61

EPS(TTM)

Face Value()

Div & Yield %

5.77

Back

Ridhi Synthetics reports standalone net profit of Rs 0.26 crore in the December 2025 quarter

Feb 13,2026

Net profit of Ridhi Synthetics remain constant at Rs 0.26 crore in the quarter ended December 2025 and also during the previous quarter ended December 2024. Sales rose 9.09% to Rs 0.12 crore in the quarter ended December 2025 as against Rs 0.11 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	0.12	0.11	9
OPM %	-41.67	-72.73	-
PBDT	0.36	0.38	-5
PBT	0.34	0.37	-8
NP	0.26	0.26	0

78,516.49 -756.84 ( -0.95%)

49,166.17 -297.40 (-0.60%)

7,084.21 -45.93 (-0.64%)

59,542.04 192.87 (0.32%)

10,480.54 -17.55 (-0.17%)

92.99 0.41 (0.45%)

109.45 0.58 (0.53%)

125.69 0.62 (0.49%)

0.59 0.00 (0.33%)